Latest biotech updates for week ended March 20

Mar 22, 2015 No Comments

Latest updates to the Company Pipeline Database for the week ending March 20. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ACRX 4.15 ARX-04 Moderate-to-severe acute pain Phase 3 Phase 3 trial initiated March 2015. Data due 4Q 2015 3/22/2015 ANTH 4.34 Blisibimod Lupus Phase 3 Missed primary endpoints […]

Read more

Updates for ACAD ANAC BIND BSTC CCXI CNAT CTIC CYTK EBIO EGLT FATE HRTX MRNS OCRX PLX PPHM SNTA SPPI TBPH TKAI TKMR XENE ZSPH

Mar 14, 2015 No Comments

Latest updates to the Company Pipeline Database. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ACAD 34.45 Pimavanserin Parkinson’s disease psychosis (PDP) Phase 3 NDA filing of Pimavanserin for Parkinson’s disease psychosis (PDP) due 2H 2015 3/14/2015 ANAC 55.66 AN2728 Mild-to-moderate atopic dermatitis Phase 3 Phase 3 […]

Read more

Updates for ADHD AKBA CYTR OCUL RDUS TBPH VSTM

Mar 11, 2015 No Comments

Latest updates to the Company Pipeline Database. Refer to the FDA Calendar for upcoming catalysts: ADHD 7.12 MDX (Metadoxine Extended Release (MG01CI)) Pediatric ADHD Phase 2b Phase 2b data released March 2015. No safety concerns but analyses of secondary cognitive measures did not produce statistically significant results 3/11/2015 AKBA 11.43 AKB-6548 Anemia related to chronic […]

Read more

SPPI PDUFA date set. KYTH Adcom approval. Setback for ACRX + updates for CTIC EDAP GLMD IMUC LGND SSH

Mar 10, 2015 No Comments

Latest updates to the Company Pipeline Database. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ACRX 5.51 ARX-04 Moderate-to-severe acute pain Phase 3 Phase 3 planned 3/10/2015 ACRX 5.51 Zalviso Post-operative pain following open abdominal surgery and hip or knee replacement surgery CRL CRL Jul 26 2014. […]

Read more

Pipeline updates for AAVL ACHN CMRX ESPR GALE NBS PBYI TTPH AKBA ALDR ARQL CORT SCMP VNDA

Mar 07, 2015 No Comments

Latest updates to the Company Pipeline Database. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated AAVL 35.96 AVA-101 Wet-AMD Phase 2a Phase 2a data due mid 2015 3/7/2015 ACHN 11.39 ACH-3102 and sovaprevir with sofosbuvir Hepatitis C viral infection (HCV) – for a treatment duration of 4 […]

Read more

Pipeline updates for AERI ALDX ALIOF AMRN AQXP ATHX BLRX BOTA CVM DRRX DVAX GERN MDCO MGNX PCRX PTLA RCPT RIGL RVNC THLD TNXP TTHI XLRN

Mar 04, 2015 No Comments

Latest updates to the Company Pipeline Database for March 2-3, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated AERI 28.60 Rhopressa Glaucoma Phase 3 Phase 3 Rocket 1 trial data due mid-2Q 2015. Rocket 2 data due mid 2Q 2015 3/4/2015 AERI 28.60 Roclatan Glaucoma Phase 3 […]

Read more

MDCO Adcom date set + updates for ACAD ATRA BOTA CMRX GEVA HPTX HSGX ISIS KERX MACK NLNK OTIC PTCT RPTP SAGE SRPT TLOG VICL ZIOP

Feb 28, 2015 No Comments

Latest updates to the Company Pipeline Database for February 26-27, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ACAD 37.97 Pimavanserin Parkinson’s disease psychosis (PDP) Phase 2 NDA filing due 1Q 2015 2/28/2015 ATRA 19.56 PINTA 745 Protein-energy wasting Phase 2 Phase 2 unblinding of data […]

Read more

Pipeline updates for ALKS ARDX ATRS BMRN CEMP CLDX CLVS DPRX DYAX EXEL FLXN INFI NKTR TBPH XOMA

Feb 26, 2015 No Comments

Latest updates to the Company Pipeline Database for February 24-25, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ALKS 71.11 ALKS 5461 Major depressive disorder Phase 2 Phase 3 (two trials) initiated Jun 2014. Data due 2016. Third Phase 3 trial initiated mid 2014. Data due […]

Read more

BDSI ENDP GEVA ICNY OPHT updates

Feb 24, 2015 No Comments

Latest updates to the Company Pipeline Database for Monday February 23, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated BDSI 14.63 BEMA Buprenorphine Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate PDUFA Announced Dec 23 […]

Read more